Finance Committee Chairman Sen. Max Baucus (D., Mont.).


September 15, 2009 - The Finance Committee in a health-overhaul bill calls for device makers to pay $40 billion in fees over 10 years, with the specific amount based on each company's market share.

Meanwhile, medical-device manufacturers are rushing to reverse billions of dollars in fees proposed by the Senate Finance Committee. The fees resulted from a lobbying move where medical device-makers went to the White House this spring to volunteer financial concessions as part of an overhaul where they were asked to provide a financial figures in savings. The companies suggested that instead the government should tax hospital-purchasing groups (GPOs) that negotiate for lower prices on medical supplies and some devices. This way, they reasoned, the GPOs would pass on some or all of that tax to the device makers.

Finance Committee Chairman Sen. Max Baucus (D., Mont.), plans to make public his bill today, and the new fees on device makers' revenues are expected to be part of the new law. According to the bill, all manufacturers would be assessed at a rate based upon their U.S. sales to generate $4 billion annually beginning in 2010.

Some say the government believes device makers will greatly benefit from an overhaul because wider insurance coverage will bring them more customers, and the White House wants savings commitments to help pay for the package.


Related Content

News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
Feature | PET-CT | By Melinda Taschetta-Millane

According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...

Time January 17, 2024
arrow
News | Prostate Cancer

January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...

Time January 05, 2024
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
News | RSNA

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
Subscribe Now